Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cell ; 187(7): 1666-1684.e26, 2024 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-38490194

RESUMO

Diminished hepatocyte regeneration is a key feature of acute and chronic liver diseases and after extended liver resections, resulting in the inability to maintain or restore a sufficient functional liver mass. Therapies to restore hepatocyte regeneration are lacking, making liver transplantation the only curative option for end-stage liver disease. Here, we report on the structure-based development and characterization (nuclear magnetic resonance [NMR] spectroscopy) of first-in-class small molecule inhibitors of the dual-specificity kinase MKK4 (MKK4i). MKK4i increased liver regeneration upon hepatectomy in murine and porcine models, allowed for survival of pigs in a lethal 85% hepatectomy model, and showed antisteatotic and antifibrotic effects in liver disease mouse models. A first-in-human phase I trial (European Union Drug Regulating Authorities Clinical Trials [EudraCT] 2021-000193-28) with the clinical candidate HRX215 was conducted and revealed excellent safety and pharmacokinetics. Clinical trials to probe HRX215 for prevention/treatment of liver failure after extensive oncological liver resections or after transplantation of small grafts are warranted.


Assuntos
Inibidores Enzimáticos , Falência Hepática , MAP Quinase Quinase 4 , Animais , Humanos , Camundongos , Hepatectomia/métodos , Hepatócitos , Fígado , Hepatopatias/tratamento farmacológico , Falência Hepática/tratamento farmacológico , Falência Hepática/prevenção & controle , Regeneração Hepática , Suínos , MAP Quinase Quinase 4/antagonistas & inibidores , Inibidores Enzimáticos/uso terapêutico
2.
ACS Appl Mater Interfaces ; 10(51): 44452-44462, 2018 Dec 26.
Artigo em Inglês | MEDLINE | ID: mdl-30511570

RESUMO

Advanced lithium-ion batteries are of great interest for consumer electronics and electric vehicle applications; however, they still suffer from drawbacks stemming from cathode active material limitations (e.g., insufficient capacities and capacity fading). One approach for alleviating such limitations and stabilizing the active material structure may be anion doping. In this work, fluorine and nitrogen are investigated as potential dopants in Li1.02(Ni0.8Co0.1Mn0.1)0.98O2 (NCM) as a prototypical nickel-rich cathode active material. Nitrogen doping is achieved by ammonia treatment of NCM in the presence of oxygen, which serves as an unconventional and new approach. The crystal structure was investigated by means of Rietveld and pair distribution function analysis of X-ray diffraction data, which provide very precise information regarding both the average and local structure, respectively. Meanwhile, time-of-flight secondary-ion mass spectroscopy was used to assess the efficacy of dopant incorporation within the NCM structure. Moreover, scanning electron microscopy and scanning transmission electron microscopy were conducted to thoroughly investigate the dopant influences on the NCM morphology. Finally, the electrochemical performance was tested via galvanostatic cycling of half- and full-cells between 0.1 and 2 C. Ultimately, a dopant-dependent modulation of the NCM structure was found to enable the enhancement of the electrochemical performance, thereby opening a route to cathode active material optimization.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA